NEW: Premarket Now Starts at 4AM!

We’re excited to announce the extension of premarket and aftermarket hours! Our members now have access to quotes daily from 4:00 AM to 8:00 PM ET — offering greater flexibility and deeper insights into market trends beyond regular trading hours.

Upgrade to FINVIZ*Elite to access premarket quotes »

ADGM

Adagio Medical Holdings Inc

May 23 • 04:00PM ET

1.19

Dollar change +0.04
Percentage change 3.48	%

Healthcare • Medical Devices • USA • NASD

Peers: BSX STXS EW LXRX NVRO CUTR BLFS CLPT

Scroll to Statements

Index	-	P/E	-	EPS (ttm)	-11.04	Insider Own	1.81%	Shs Outstand	15.38M	Perf Week	0.85%
Market Cap	18.30M	Forward P/E	-	EPS next Y	-	Insider Trans	0.00%	Shs Float	15.10M	Perf Month	4.39%
Income	-74.74M	PEG	-	EPS next Q	-	Inst Own	75.37%	Short Float	2.23%	Perf Quarter	-22.22%
Sales	0.58M	P/S	31.55	EPS this Y	-	Inst Trans	66.86%	Short Ratio	0.17	Perf Half Y	-51.23%
Book/sh	0.81	P/B	1.48	EPS next Y	-	ROA	-295.04%	Short Interest	0.34M	Perf Year	-89.45%
Cash/sh	0.84	P/C	1.41	EPS next 5Y	-	ROE	-329.16%	52W Range	0.62 - 11.57	Perf YTD	13.33%
Dividend Est.	-	P/FCF	-	EPS past 5Y	-816.44%	ROI	-243.29%	52W High	-89.71%	Beta	0.06
Dividend TTM	-	Quick Ratio	2.51	Sales past 5Y	-25.00%	Gross Margin	-449.39%	52W Low	90.40%	ATR (14)	0.16
Dividend Ex-Date	-	Current Ratio	2.89	EPS Y/Y TTM	-4.40%	Oper. Margin	-5822.92%	RSI (14)	50.18	Volatility	2.82% 4.16%
Employees	80	Debt/Eq	1.50	Sales Y/Y TTM	2115.38%	Profit Margin	-12975.00%	Recom	-	Target Price	-
Option/Short	No / Yes	LT Debt/Eq	1.48	EPS Q/Q	95.12%	Payout	-	Rel Volume	0.02	Prev Close	1.15
Sales Surprise	-	EPS Surprise	-	Sales Q/Q	-100.00%	Earnings	-	Avg Volume	2.01M	Price	1.19
SMA20	-5.07%	SMA50	11.93%	SMA200	-44.96%	Trades		Volume	41,453	Change	3.48%

May-15-25 04:05PM	Adagio Medical Reports First Quarter 2025 Results (Business Wire)
May-07-25 08:30AM	Adagio Medical to Present at the BofA Securities 2025 Health Care Conference (Business Wire)
Apr-17-25 08:30AM	Adagio Medical Holdings, Inc. Receives FDA Breakthrough Device Designation for the vCLASTM Cryoablation System (Business Wire) +92.81%
Mar-31-25 04:01PM	Adagio Medical Appoints Deborah Kaster as Chief Business Officer (Business Wire) -14.36%
08:30AM	Adagio Medical Reports Fourth Quarter and Full Year 2024 Results (Business Wire)
04:01PM	Loading…
Mar-17-25 04:01PM	Adagio Medical Provides Clinical and Business Updates (Business Wire) -7.41% -9.00%
Feb-28-25 08:30AM	Adagio Medical Announces Strategic Restructuring to Accelerate US Pivotal IDE Trial and Product Innovation (Business Wire) -45.94%
Feb-18-25 04:01PM	Adagio Medical to Participate at the TD Cowen's 45th Annual Health Care Conference (Business Wire)
Dec-16-24 08:00AM	Adagio Medical Announces Appointment of Accomplished Medical Device Leader Todd Usen as Chief Executive Officer and Director (Business Wire) -9.41%
Nov-14-24 04:01PM	Adagio Medical Reports Third Quarter 2024 Results (Business Wire) +57.87% -19.14%
Nov-04-24 04:01PM	Adagio Medical to Present at the Stifel 2024 Healthcare Conference (Business Wire) +7.75%
Oct-24-24 08:30AM	Adagio Medical Announces Completion of First Procedures in FULCRUM-VT U.S. FDA Pivotal IDE of Ventricular Tachycardia Cryoablation System (Business Wire)
Oct-07-24 04:01PM	Adagio Medical Announces Participation in the 19th Annual International Symposium on Ventricular Arrhythmias (Business Wire) -7.14%
Aug-19-24 04:01PM	Adagio Medical Provides Business Updates (Business Wire)

Adagio Medical Holdings, Inc. is a medical device company, which engages in the development ablation technologies for the treatment of cardiac arrhythmias. It treats atrial fibrillation, atrial flutter, and ventricular tachycardia. The company was founded on August 24, 2020 and is headquartered in Laguna Hills, CA.

open in yahoo | open in reuters | open in marketwatch | open in google | open in EDGAR

ADGM

Adagio Medical Holdings Inc

Upgrade your FINVIZ experience